Michael Link

Michael Link

Medical oncologist

Lymphoma Program

Professional Education

  • Fellowship: Dana Farber Cancer Institute Hematology Oncology Fellowship (1979) MA
  • Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1980)
  • Board Certification: Pediatrics, American Board of Pediatrics (1979)
  • Fellowship: Children's Hospital Boston (1979) MA
  • Residency: Children's Hospital Boston (1976) MA
  • Internship: Children's Hospital Boston (1975) MA
  • Medical Education: Stanford University School of Medicine (1974) CA
  • MD, Stanford University, Medicine (1974)
  • AB, Columbia College, Political Science (1970)

Honors & Awards

  • 21st Annual W.W. Sutow Visiting Lecturer in Pediatric Oncology, MD Anderson Hospital (2013)
  • Alpha Omega Alpha, Alpha Omega Alpha (1974)
  • Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)
  • Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)
  • Brent Eley Visiting Professor in Pediatric Oncology, University of Colorado Cancer Center and the Childrens Hospital, Denver (2009)
  • Honorary Fellow, The Royal Academy of Paediatrics and Child Health (June, 2013)
  • Pediatric Oncology Award and Lecture, American Society of Clinical Oncology (June, 2017)
  • Phi Beta Kappa, Phi Beta Kappa (1969)

Administrative Appointments

  • Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine (2000 - 2010)
  • Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford (2002 - 2010)
  • Lydia J. Lee Professor in Pediatric Cancer, Stanford University (2003 - Present)
  • President, American Society of Clinical Oncology (2011 - 2012)
  • President-Elect, American Society of Clinical Oncology (2010 - 2011)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.